During the past decade, Hospital do Divino Espírito Santo conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital do Divino Espírito Santo" are "Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Anesthesia" (1 trials), "Colorectal Carcinoma" (1 trials) and "Curarization, Postoperative Residual" (1 trials). Many other conditions were trialed in "Hospital do Divino Espírito Santo" in a lesser frequency.

Most popular intervention types in "Hospital do Divino Espírito Santo" are "Device" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetuximab" (1 trials), "Dose of sugammadex according to SSD and QSD" (1 trials), "Fractional Flow Reserve" (1 trials) and "XIENCE Sierra" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital do Divino Espírito Santo" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hospital do Divino Espírito Santo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital do Divino Espírito Santo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital do Divino Espírito Santo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".